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clinical outcomes, except glycemic level was 24 months. Glycemic level was measured for the final time at 36 months after randomisation. No loss to follow-up was reported.
Analysis of effectiveness
The principal (intention to treat or treatment completers only) used in the analysis of the clinical outcomes was not specified. The main health outcome measures were glycemic level (percentage of glycosylatedhaemoglobin HbA1c in the blood) and the incidence of adverse events (hyperglycemia with ketosis, diabetic ketoacidosis, severe hypoglycemia, and chronic hyperglycemia). The psychological aspects of adjustment to diabetes and school absence were also measured. The groups at diagnosis were shown comparable in terms of age, gender, socioeconomic status, glycemic (HbA1c) levels, and insulin dosage.
Effectiveness results
It was discovered that in terms of mean glycemic level, there was no significant difference between the groups at diagnosis (home care 10.7% versus traditional care 10.0%, P>0.26), and at 12 months (home care 6.4% versus traditional care 6.1%, P>0.55). The corresponding values at 24 and 36 months were 6.1% versus 6.8%, P<0.02 and 6.4% versus 7.1%, P<0.05, respectively. The number of incidents of adverse diabetes-related clinical events were 32 in the home care group against 31 in the traditional care group. In terms ofpsychological aspects of adjustment to diabetes, no significant differences between the groups were detected. The p-value for the difference in school absence was greater than 0.85.
Clinical conclusions
The authors concluded that "home care improved the children's metabolic outcomes without adversely affecting their psychological adjustment to diabetes". The "key health effect finding was that the home care group had better glycemic control".
Measure of benefits used in the economic analysis
The main health outcome measures were glycemic level (percentage of glycosylatedhaemoglobin HbA1c in the blood quarterly measured) and the incidence of adverse events (hyperglycemia with ketosis, diabetic ketoacidosis, severe hypoglycemia, and chronic hyperglycemia).
Direct costs
Costs were discounted. Resource utilisation was reported separately from costs. Cost items were not reported separately. The cost items consisted of the cost of hospital services (including a wide range of services), costs of drugs, costs of physician contacts, costs of psychological counselling and diabetic nursing services, the cost of government contribution to pension plan for hospital staff, and the parents' out-of-pocket spending.
The cost results were reported in terms of cost effects (the difference in costs between the study groups). The main perspective adopted by the study was societal, although the cost results were also calculatedfrom the perspective of the government, the hospital, the health care system, and the parents.
The main source of resource utilisation data was the study hospital records and staff judgements. The main sources of cost data were the study hospital records, Quebec's physician fee scale in 1991, and parental information, collected using a questionnaire, regarding out-of-pocket spending. The date to which the price data referred was 1991. The government's allowance for insulin and medical supplies to all families, a few diabetes-related health services not provided in the study hospital, and the values of residents' and interns' services were not included in the cost analysis (the cost results were insensitive to these omissions). The lower future health costs due to better health outcomes for the patients in the home care group were not considered in the study.
